A WELLNESS PRODUCTION FUNCTION ALLOCATING SCARCE DOLLARS FOR HEALTH OR LEISURE von Simons, WR

Volltext

CAUSALITY WITH REAL WORLD EVIDENCE: BURDEN OF PROOF, PROOF OF PRINCIPLE von Simons, WR

Volltext

WH2 STANDARD GAMBLE TECHNIQUES FOR THE MEASUREMENT OF TREATMENT RELATED TOXICITY IN ONCOLOGY: APPLICATION TO BREAST CANCER von Simons, WR

Volltext

A population-based European cohort study of persistence in newly diagnosed hypertensive patients von HASFORD, J, MIMRAN, A, SIMONS, W. R

Volltext

AN ECONOMIC PROOF AND APPLICATION THAT FORMULARY RESTRICTIONS WITHIN DRUG CLASSES ALWAYS RESULT IN HIGHER COSTS von Simons, Wr

Volltext

PCV47 THE QUANTIFICATION OF THE RELATIONSHIP BETWEEN HIGH DENSITY LIPOPROTEIN CHOLESTEROL (HDL-C) AND ALL-CAUSE MORTALITY von Simons, WR, Edwards, DM

Volltext

PDB16 REPLICATION AND VALIDATION OF THE QUANTIFICATION OF THE RELATIONSHIP BETWEEN PHARMACOLOGIC INTERVENTION, REDUCTIONS IN HBA1C AND REDUCTIONS IN COMPLICATIONS: ITS APPLICATION... von Simons, WR, Hagan, MA

Volltext

DB4 COST OF DIABETIC-RELATED COMPLICATIONS AND CARDIOVASCULAR EVENTS BY TYPE OF EVENT AND SETTING ANNUALLY FOR THE FIRST THREE YEARS FOLLOWING ITS ONSET von Simons, WR, Hagan, MA

Volltext

PCV100 THE RELATIONSHIP BETWEEN HIGH DENSITY LIPOPROTEIN CHOLESTEROL (HDL-C), NICOTINIC ACID AND ALL-CAUSE MORTALITY von Simons, WR, Edwards, DM

Volltext

Variations in compliance among hypertensive patients by drug class: implications for health care costs von Rizzo, John A., Robert Simons, W.

Volltext

Comparative cost effectiveness of angiotensin II receptor blockers in a US managed care setting: Olmesartan medoxomil compared with losartan, valsartan, and irbesartan von SIMONS, W. Robert

Volltext

PMS30 THE ECONOMIC CONSEQUENCES OF RHEUMATOID ARTHRITIS: ANALYSIS OF THE MEDICAL EXPENDITURE PANEL SURVEY (MEPS) 2005 AND 2006 DATA von Simons, WR, Chang, CY, Trivedi, DN, Rosenblatt, LC

Volltext

COST‐UTILITY ANALYSIS OF QUETIAPINE COMPARED TO RISPERIDONE IN THE TREATMENT OF PATIENTS WITH SCHIZOPHRENIA OR OTHER PSYCHOTIC DISORDERS von Simons, Wr, Meddis, D

Volltext

Cost-effectiveness of anastrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer von Simons, W.Robert, Jones, David, Buzdar, Aman

Volltext

PMS20 THE ECONOMIC CONSEQUENCES OF RHEUMATOID ARTHRITIS: AN ANALYSIS OF THE MEDICAL EXPENDITURE PANEL SURVEY (MEPS) von Simons, WR, Rosenblatt, LC, Trivedi, DN

Volltext

PCN48 STANDARD GAMBLE TECHNIQUES FOR THE MEASUREMENT OF TREATMENT RELATED TOXICITY IN ONCOLOGY: APPLICATION TO ADVANCED STAGE PROSTATE CANCER von Simons, WR, Tung, PJ, Pan, KY

Volltext

PCN1 QUALITY-ADJUSTED TIME WITHOUT SYMPTOMS AND TOXICITY (Q-TWIST) OF FOTEMUSTINE COMPARED WITH DACARBAZINE IN PATIENTS WITH DISSEMINATED MALIGNANT MELANOMA von Simons, WR, Aamdal, S, Hauschild, A, Mohr, P, Grob, JJ

Volltext

PDB8 AN ANALYSIS OF THE RELATIONSHIP BETWEEN RAPID TRANSITION TO INSULIN, AREA UNDER THE CURVE FOR HBA1C MEASURES ACROSS TIME AND DIABETESRELATED COMPLICATIONS: A GERMANY POPULATIO... von Simons, WR, Bolinder, B, Vinod, H

Volltext

PMH27: COST-UTILITY ANALYSIS OF QUETIAPINE COMPARED TO RISPERIDONE IN THE TREATMENT OF PATIENTS WITH SCHIZOPHRENIA OR OTHER PSYCHOTIC DISORDERS von Simons, WR, Meddis, D

Volltext

PMH9 THE DIRECT AND INDIRECT ECONOMIC COSTS OF PSYCHOTIC DISORDERS TO BOTH PATIENTS AND CAREGIVERS von Simons, WR, White, R, Bassi, R

Volltext